Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study. - Wikidata - awgldk - TriplyDB

Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study.

Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study.

http://www.wikidata.org/entity/Q35175902

about

Getting to 90-90-90 in paediatric HIV: What is needed?Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children Achieving 90-90-90 in paediatric HIV: adolescence as the touchstone for transition success.Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals.Unresolved antiretroviral treatment management issues in HIV-infected children Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.Metabolic complications and treatment of perinatally HIV-infected children and adolescents.Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.

P2860

Q30385352-50B3B99D-1E80-401C-B448-C2BC731F83FC Q35926011-4ED0697A-49FD-4500-8710-2500A4C7EA88 Q36349683-A95D3529-0423-4644-82C0-07A77F0E7D06 Q36349706-A7512A9A-F291-4832-90B4-025AE355ED51 Q36381307-F5E0B5BE-9869-408C-9B3D-6A9AC4AA8B32 Q36781481-48E44401-9024-416A-AE97-01919220383C Q36941650-B389212F-94C4-42F3-9A69-E438232ADD82 Q36952291-F3EC465F-79DB-4020-A130-A482875C9F42 Q47602387-06240CDD-3030-4B51-A780-3A7A2AD256F6

P2860

Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study.

http://www.wikidata.org/entity/Q35175902

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clinical management and follow ...... olled in the PACTG 219C study.

@ast

Clinical management and follow ...... olled in the PACTG 219C study.

@en

type

label

Clinical management and follow ...... olled in the PACTG 219C study.

@ast

Clinical management and follow ...... olled in the PACTG 219C study.

@en

prefLabel

Clinical management and follow ...... olled in the PACTG 219C study.

@ast

Clinical management and follow ...... olled in the PACTG 219C study.

@en

P1433

Q35175902-EBFCF186-E64F-408C-BFFA-E6B4AA613D79

P1476

Q35175902-CB29ECE6-9836-42BC-BF85-88DF03B90F6F

P2093

Q35175902-1BB2A3AD-9B8B-41B0-852F-7659BD27519F

Q35175902-3A3AC068-86CA-4E86-BB68-09AE6A973B9D

Q35175902-B75ADAD1-A3E2-4789-A8C1-F62B7B27BF47

Q35175902-C2679198-BA2A-4A61-BB97-8514EF08D817

Q35175902-D6AE2AAC-D023-4779-98CC-750B629A8452

Q35175902-E579082D-E26D-4438-9887-404C7D4F84FC

P2860

Q35175902-000D4659-68D0-4CBC-855B-D0E5804D8CBF

Q35175902-086F6CE9-2012-460D-B6FC-4F0F8BD306C8

Q35175902-093C864E-97F2-4D82-AC90-44EFA778F55A

Q35175902-11113DFE-F141-41F8-93A9-84D95AD4045C

Q35175902-1AD50617-C98A-4714-A614-4525C62D21B2

Q35175902-2542F15E-C668-4BE5-8F4A-07F5AE98D345

Q35175902-2FE750AB-1399-4FC9-9953-9FCFEC0184C4

Q35175902-3463AF64-F6D8-47BF-9DA1-D05B59E3C932

Q35175902-3C570DD7-88CB-4D72-974A-E52B6111F2B3

Q35175902-43545E05-016E-4603-AB3D-542F7F970D42

P304

Q35175902-3144417B-CC93-444E-BC77-FC4865F479D1

P31

Q35175902-7D03D8AD-9C66-4E8D-B6DB-6C3217F1C8E5

P356

Q35175902-41F6F2BD-572D-4232-9214-62A0374A56F8

P407

Q35175902-CED9A539-C91C-4B39-9C52-142A96978A04

P433

Q35175902-90FCBEEB-2E8C-4C44-8C45-BE5D3019996B

P478

Q35175902-F0368B61-7032-4743-A874-EE683386F40A

P577

Q35175902-4AFBF197-6164-447A-B928-43CA80BC06DF

P698

Q35175902-EBB75E94-E5FF-42BB-A93A-7CFAC206B2EA

P921

Q35175902-48EC27EE-B292-4922-90F0-E3B6AB809CC4

P932

Q35175902-C6D96677-9D28-467E-9486-B064F961AA2E

P356

QAI.0B013E31822203F5

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Clinical management and follow ...... olled in the PACTG 219C study.

@en

P2093

Ann Melvin

http://www.w3.org/2001/XMLSchema#string

Denise L Jacobson

http://www.w3.org/2001/XMLSchema#string

John Farley

http://www.w3.org/2001/XMLSchema#string

Katherine Tassiopoulos

http://www.w3.org/2001/XMLSchema#string

Paige Williams

http://www.w3.org/2001/XMLSchema#string

Rohan Hazra

http://www.w3.org/2001/XMLSchema#string

P2860

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children.

Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children.

Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.

Lipid screening and cardiovascular health in childhood.

Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

P304

413-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E31822203F5

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21602698

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

3159838

http://www.w3.org/2001/XMLSchema#string